TFF PHARMACEUTICALS INC's ticker is TFFP and the CUSIP is 87241J104. A total of 42 filers reported holding TFF PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $350 | -25.5% | 1,000 | 0.0% | 0.00% | – |
| Q2 2023 | $470 | -31.4% | 1,000 | 0.0% | 0.00% | – |
| Q1 2023 | $685 | -31.5% | 1,000 | 0.0% | 0.00% | – |
| Q4 2022 | $1,000 | -75.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2022 | $4,000 | -50.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2021 | $8,000 | -52.9% | 1,000 | -41.9% | 0.00% | – |
| Q2 2021 | $17,000 | -45.2% | 1,720 | -22.5% | 0.00% | – |
| Q1 2021 | $31,000 | +82.4% | 2,220 | +82.0% | 0.00% | – |
| Q4 2020 | $17,000 | -54.1% | 1,220 | -39.6% | 0.00% | – |
| Q3 2020 | $37,000 | – | 2,020 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 1,058,823 | $19,556,000 | 9.92% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | 220,666 | $4,076,000 | 4.24% |
| Mesirow Financial Investment Management, Inc. | 34,902 | $645,000 | 2.76% |
| Gagnon Advisors, LLC | 176,471 | $3,259,000 | 2.00% |
| Nantahala Capital Management | 2,032,988 | $37,549,000 | 1.15% |
| PRECEPT MANAGEMENT LLC | 235,294 | $4,346,000 | 1.07% |
| GAGNON SECURITIES LLC | 219,584 | $4,056,000 | 0.86% |
| Sepio Capital, LP | 84,560 | $1,562,000 | 0.17% |
| 683 Capital Management, LLC | 117,647 | $2,173,000 | 0.16% |
| SANDERS MORRIS HARRIS LLC | 21,326 | $340,000 | 0.09% |